These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 31439824
1. Serial measurements of cardiac troponin I in heart failure secondary to canine mitral valve disease. Chan IP, Wu SY, Chang CC, Chen WY. Vet Rec; 2019 Sep 21; 185(11):343. PubMed ID: 31439824 [Abstract] [Full Text] [Related]
2. Serial analysis of serum cardiac troponin I changes and correlation with clinical findings in 46 dogs with mitral valve disease. Polizopoulou ZS, Koutinas CK, Dasopoulou A, Patsikas M, York M, Roman I, Gandhi M, Patel S, Koutinas AF, O'Brien PJ. Vet Clin Pathol; 2014 Jun 21; 43(2):218-25. PubMed ID: 24612252 [Abstract] [Full Text] [Related]
3. Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease. Falk T, Ljungvall I, Zois NE, Höglund K, Olsen LH, Pedersen HD, Häggström J. J Vet Intern Med; 2013 Jun 21; 27(3):500-6. PubMed ID: 23551840 [Abstract] [Full Text] [Related]
4. Correlation of serum cardiac troponin I and acute phase protein concentrations with clinical staging in dogs with degenerative mitral valve disease. Polizopoulou ZS, Koutinas CK, Cerón JJ, Tvarijonaviciute A, Martínez-Subiela S, Dasopoulou A, York MJ, Roman IF, Gandhi M, Patel S, O'Brien PJ. Vet Clin Pathol; 2015 Sep 21; 44(3):397-404. PubMed ID: 26288324 [Abstract] [Full Text] [Related]
9. Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease. Druzhaeva N, Nemec Svete A, Ihan A, Pohar K, Domanjko Petrič A. J Vet Intern Med; 2021 Sep 21; 35(5):2112-2122. PubMed ID: 34236111 [Abstract] [Full Text] [Related]
13. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease. Reimann MJ, Ljungvall I, Hillström A, Møller JE, Hagman R, Falk T, Höglund K, Häggström J, Olsen LH. Vet J; 2016 Mar 21; 209():113-8. PubMed ID: 26831162 [Abstract] [Full Text] [Related]
14. Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease. Franchini A, Abbott JA, Tyrrell W, Rosenthal S, Lahmers S, Menciotti G, Crosara S, Häggström J, Borgarelli M. J Vet Cardiol; 2021 Apr 21; 34():112-119. PubMed ID: 33706221 [Abstract] [Full Text] [Related]
15. Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs. Lee CM, Jeong DM, Kang MH, Kim SG, Han JI, Park HM. Am J Vet Res; 2017 Apr 21; 78(4):440-446. PubMed ID: 28345991 [Abstract] [Full Text] [Related]
16. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation. Morgan KRS, Monteith G, Raheb S, Colpitts M, Fonfara S. Vet J; 2020 Sep 21; 263():105518. PubMed ID: 32928487 [Abstract] [Full Text] [Related]
18. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs. Nakamura K, Kawamoto S, Osuga T, Morita T, Sasaki N, Morishita K, Ohta H, Takiguchi M. J Vet Intern Med; 2017 Mar 21; 31(2):316-325. PubMed ID: 28145607 [Abstract] [Full Text] [Related]